1 day Ago By Defense World Staff
Envoy Medical, Inc. ( NASDAQ:COCH – Get Free Report ) was the target of a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 23,500 shares, a growth of 5.
9% from the August 15th total of 22,200 shares. Currently, 0.4% of the company’s stock are short sold.
Based on an average daily trading volume, of 22,000 shares, the days-to-cover ratio is presently 1.1 days. Envoy Medical Stock Down 3.
1 % Shares of Envoy Medical stock traded down $0.10 on Wednesday, reaching $3.11.
The company’s stock had a trading volume of 4,018 shares, compared to its average volume of 173,691. The firm’s fifty day simple moving average is $2.67 and its two-hundred day simple moving average is $3.
54. Envoy Medical has a 52 week low of $0.75 and a 52 week high of $11.
72. Envoy Medical ( NASDAQ:COCH – Get Free Report ) last posted its earnings results on Monday, August 12th. The company reported ($0.
27) EPS for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.03).
The business had revenue of $0.07 million during the quarter, compared to analyst estimates of $0.08 million.
Equities analysts predict that Envoy Medical will post -1.36 EPS for the current fiscal year. Wall Street Analysts Forecast Growth Read Our Latest Report on COCH Institutional Trading of Envoy Medical Large investors have recently modified their holdings of the company.
Weiss Asset Management LP bought a new stake in shares of Envoy Medical in the fourth quarter worth $37,000. WealthTrust Asset Management LLC bought a new stake in shares of Envoy Medical in the first quarter worth $44,000. Finally, Virtu Financial LLC bought a new stake in shares of Envoy Medical in the first quarter worth $55,000.
Institutional investors own 8.59% of the company’s stock. Envoy Medical Company Profile ( Get Free Report ) Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum.
Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023. Featured Articles Five stocks we like better than Envoy Medical What Does Downgrade Mean in Investing? How Much Can You Make in Stocks in One Month? The Top 3 Healthcare Dividend Stocks to Buy and Hold This Is the Top Large-Cap Stock Insiders Are Buying Conference Calls and Individual Investors Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.
com's FREE daily email newsletter ..
